IDD 1

N/A

Report date: 2022/03/23 17:09:30

Base Information

Drug NameIDD 1

Drug Alias NameIDD-1Dendritic cell/recombinant prostate-specific antigen vaccineProstate cancer vaccine - IDM PharmaDendritophages/rPSA vaccineEladem-2 +[7]

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesIdm Pharma

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIdm Pharma

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A